ProGen Search
Intelligence Vault
Radiopharma

Isotope Supply Security Assessment: Preview Report

A free preview of how ProGen assesses the security of a medical isotope supply. It breaks the chain into six links, from enriched target to patient, tests each against seven dimensions of exposure, and keeps one record for every production asset behind a scored isotope. Scores are reserved for buyers.

PDF9 pagesPublished November 2026Free

Built to order · Research cut-off: 18 November 2026

What this report answers

  • How many independent assets carry supply of an isotope, and how much rests on the largest?
  • How old are those assets, how often have they stopped, and when are they replaced?
  • Where does the target material come from, and which export controls or sanctions reach it?
  • How far can a dose travel before decay makes it unusable?
  • Is a second source qualified, or only contracted, and does it share a failure point with the first?

61 outage and disruption events

Dated reactor stops, processing, generator, finished-product, transport and supply-notice events from 2008 to 2026, each with dates and cause.

25 asset records

Reactors, accelerators and processing sites, each with one record of the same shape.

What the analysis establishes

Seven dimensions of exposure

Production concentration, asset age and reliability, target and feedstock, geopolitical and regulatory exposure, logistics reach, qualified backup depth and demand pressure. Each is scored 1 to 5 against written anchors and read as a profile beside a total from 7 to 35.

The asset register

25 asset records, 15 of them reactor records, each in the same shape: age, operating pattern, license term, replacement and its date, stops since 2008, target material and the controls that reach it. The preview shows one record field by field, with its scores withheld.

Disruptions, feedstock and controls

61 dated outage and disruption events cataloged from 2008 to 2026; 15 target materials traced to their enrichers and countries; 25 export control, sanctions and policy measure records across China, the European Union, the United States and Russia.

Backup depth and correlated failure

19 developer filings from 14 filers screened and 26 supply relationship records, read to separate a qualified second source from a signed contract, and to test whether a backup shares a reactor, a target enricher, a processor or a jurisdiction with the primary.

Built to your decision

Each assessment is scoped to the decision in front of you, whether a program, a portfolio, a supply agreement, a supplier qualification or an investment thesis, and quoted on request.

About this intelligence

626 evidence records from 372 public sources, more than half of them government, regulator, intergovernmental and filing sources. Sources include public registries, regulator and intergovernmental records, legal texts, company filings and disclosures. Other sources are proprietary ProGen intelligence sources. Facts are linked to their sources; interpretation is labeled ProGen reading. Evidence is current to 18 November 2026.

Developers choosing or qualifying an isotope supplier. Investors assessing single-source risk behind a program or company. Supply chain and procurement teams planning around Lu-177, Ac-225, Pb-212 and Tb-161. Producers and CDMOs reading the exposure of their customers and competitors.

Contents

  • Why a supply security assessment
  • The questions it answers
  • How the assessment is built
  • The chain, link by link
  • Seven dimensions of exposure
  • Reading a score
  • The asset register
  • One record, field by field
  • Disruption history, 2008 to 2026
  • Target material and its geography
  • Controls and sanctions
  • Logistics reach
  • Backup depth and correlated failure
  • The supplier due-diligence checklist
  • What a buyer receives

Isotope profiles

Lutetium-177 (no-carrier-added), Lutetium-177 (carrier-added), Actinium-225, Lead-212, Terbium-161, Radium-223, Iodine-131, Yttrium-90, Molybdenum-99 and technetium-99m, Gallium-68, Copper-64, Fluorine-18 (control)

Free report

The full 9-page briefing is free. Tell us where to send it and it downloads immediately.

Going deeper

The Isotope Production Map

Built to your question and quoted individually: every producer, route and capacity tier in medical isotope supply, refreshed quarterly.

See the analysis →

Related analysis